Home/Filings/4/0001944048-25-000226
4//SEC Filing

Tillett Caroline 4

Accession 0001944048-25-000226

CIK 0001944048other

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 5:48 PM ET

Size

25.6 KB

Accession

0001944048-25-000226

Insider Transaction Report

Form 4
Period: 2025-12-15
Tillett Caroline
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-12-15+23,15868,037.51 total
  • Tax Payment

    Common Stock

    2025-12-15$17.28/sh11,846$204,69956,191.51 total
  • Exercise/Conversion

    Common Stock

    2025-12-15+2,99459,185.51 total
  • Tax Payment

    Common Stock

    2025-12-15$17.28/sh1,532$26,47357,653.51 total
  • Exercise/Conversion

    Common Stock

    2025-12-15+4,399.0662,052.57 total
  • Tax Payment

    Common Stock

    2025-12-15$17.21/sh2,251$38,74059,801.57 total
  • Exercise/Conversion

    Common Stock

    2025-12-15+3,371.5863,173.15 total
  • Tax Payment

    Common Stock

    2025-12-15$17.21/sh1,725$29,68761,448.15 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-12-1523,1580 total
    Common Stock (23,158 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-12-152,9940 total
    Common Stock (2,994 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-12-154,399.064,399.16 total
    Common Stock (4,399.06 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-12-153,371.586,740.09 total
    Common Stock (3,371.58 underlying)
Footnotes (10)
  • [F1]Shares withheld for payment of taxes upon vesting of Restricted Stock Units ("RSUs").
  • [F10]This award was scheduled to vest in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date but the vesting of the portion reflected herein was accelerated from 03/10/2026 in connection with the Section 280G Mitigation.
  • [F2]These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 2023, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level.
  • [F3]This award was scheduled to vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date but vesting was accelerated in order to mitigate the adverse impact to the Issuer and the Reporting Person of Section 280G of the Internal Revenue Code in connection with the pending transaction between the Issuer and Kimberly-Clark Corporation ("Section 280G Mitigation").
  • [F4]This award will be subject to clawback in the event it is determined that the Reporting Person would not have ultimately vested in the award notwithstanding the acceleration reflected herein.
  • [F5]These RSUs were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer, were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value.
  • [F6]This award was scheduled to vest in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date but the vesting of the portion reflected herein was accelerated from 02/13/2026 in connection with the Section 280G Mitigation.
  • [F7]These units correspond 1 for 1 with the Company's common stock.
  • [F8]This award was scheduled to vest in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date but the vesting of the portion reflected herein was accelerated from 03/05/2026 in connection with the 280G Mitigation.
  • [F9]Includes RSUs acquired as dividend equivalents.

Issuer

Kenvue Inc.

CIK 0001944048

Entity typeother

Related Parties

1
  • filerCIK 0001966949

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:48 PM ET
Size
25.6 KB